Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Halozyme Therapeutics Inc.’s stock clocked out at $60.43, up 3.90% from its previous closing price of $58.16. In other words, the price has increased by $3.90 from its previous closing price. On the day, 1.86 million shares were traded. HALO stock price reached its highest trading level at $61.55 during the session, while it also had its lowest trading level at $57.625.
Ratios:
To gain a deeper understanding of HALO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.75. For the most recent quarter (mrq), Quick Ratio is recorded 6.21 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 5.19 whereas as Long-Term Debt/Eq ratio is at 5.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $57 from $52 previously.
On June 07, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also upped its target price recommendation from $48 to $51.
On February 29, 2024, TD Cowen started tracking the stock assigning a Outperform rating and target price of $54.TD Cowen initiated its Outperform rating on February 29, 2024, with a $54 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 24 ’24 when Torley Helen sold 10,000 shares for $58.21 per share. The transaction valued at 582,100 led to the insider holds 676,744 shares of the business.
Torley Helen sold 10,000 shares of HALO for $563,370 on Sep 25 ’24. The PRESIDENT AND CEO now owns 676,744 shares after completing the transaction at $56.34 per share. On Sep 26 ’24, another insider, Torley Helen, who serves as the PRESIDENT AND CEO of the company, sold 10,000 shares for $56.10 each. As a result, the insider received 560,970 and left with 676,744 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 7655151616 and an Enterprise Value of 8659317760. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.43, and their Forward P/E ratio for the next fiscal year is 12.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.77 while its Price-to-Book (P/B) ratio in mrq is 26.42. Its current Enterprise Value per Revenue stands at 9.916 whereas that against EBITDA is 18.01.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $65.53, while it has fallen to a 52-week low of $32.83. The 50-Day Moving Average of the stock is 3.05%, while the 200-Day Moving Average is calculated to be 31.23%.
Shares Statistics:
It appears that HALO traded 1.30M shares on average per day over the past three months and 1545470 shares per day over the past ten days. A total of 126.77M shares are outstanding, with a floating share count of 125.30M. Insiders hold about 1.09% of the company’s shares, while institutions hold 97.26% stake in the company. Shares short for HALO as of 1726185600 were 9635995 with a Short Ratio of 7.42, compared to 1723680000 on 9673467. Therefore, it implies a Short% of Shares Outstanding of 9635995 and a Short% of Float of 10.31.
